Tuesday, November 5, 2024
HomeTagsASC42

ASC42

Gannex Announces First Patient Dosed in Phase II Clinical Trial of ASC42

Gannex Pharma Co., Ltd., a wholly owned company of Ascletis Pharma Inc. announces the first patient dosed in the Phase II clinical trial of...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics